Page last updated: 2024-12-08

picrotoxinin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

picrotoxinin: toxic component of PICROTOXIN; structure; noncompetitive antagonist of ionotropic GABA-A receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

picrotoxinin : A picrotoxane sesquiterpenoid that is 3a,4,5,6,7,7a-hexahydro-1H-indene-3,7-dicarboxylic acid which is substituted at positions 3a, 6, and 7a by methyl, isopropenyl, and hydroxy groups, respectively; in which the double bond at position 2-3 has been epoxidised; and in which the carboxy groups at positions 3 and 7 have undergone gamma-lactone formation by O-alkylation to positions 4 and 5, respectively. A component of picrotoxin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24041599
CHEMBL ID1447383
MeSH IDM0079695
PubMed CID442292
CHEMBL ID47244
CHEBI ID8206
SCHEMBL ID559915
MeSH IDM0079695

Synonyms (83)

Synonym
smr001233275
MLS002153933
BRD-A37817666-001-02-2
BSPBIO_000683
NCGC00179478-01
AB00513875
picrotoxinin
PRESTWICK3_000652
BPBIO1_000753
HMS2097C05
HMS2231P04
CCG-220652
CHEMBL1447383
SR-01000838834-3
SR-01000838834-4
sr-01000838834
SR-01000838834-5
HMS3714C05
BRD-K95554982-001-03-3
gtpl2291
picrotoxinine
nsc-129537
DIVK1C_000595
KBIO1_000595
SDCCGMLS-0066690.P001
ai3-41571
(1ar-(1aalpha,2abeta,3beta,6beta,6abeta,8as*,8bbeta,9r*))-hexahydro-2a-hydroxy-8b-methyl-9-(1-methylethenyl)-3,6-methano-8h-1,5,7-trioxa cyclopenta(ij)cycloprop(a)azulene-4,8(3h)-dione
nsc 129537
picrotoxinin (from anamirta cocculus seed)
3,6-methano-8h-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3h)-dione, hexahydro-2a-hydroxy-8b-methyl-9-(1-methylethenyl)-, (1ar-(1a-alpha,2a-beta,3-beta,6-beta,6a-beta,8as*,8b-beta,9r*))-
SPECTRUM_001292
IDI1_000595
BSPBIO_003174
SPECTRUM5_001313
BIOMOL-NT_000265
BPBIO1_001035
C09529
17617-45-7
KBIO2_001772
KBIO3_002394
KBIOGR_001402
KBIO2_004340
KBIOSS_001772
KBIO2_006908
SPBIO_001130
SPECTRUM2_001085
SPECTRUM3_001437
SPECTRUM4_000911
NINDS_000595
NCGC00142524-03
(-)-picrotoxinin
LMPR0103540001
CHEMBL47244 ,
chebi:8206 ,
HMS501N17
picrotoxinin1-hydroxy-14-isopropenyl-13-methyl-(1r,3r,5s,8s,9r,12s,13r,14r)-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione(picrotoxinin)
1-hydroxy-14-isopropenyl-13-methyl-(1r,3r,5s,8s,9r,12s,13r,14r)-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione
3-(1-methyl-pyrrolidin-2-yl)-pyridine
1-hydroxy-14-isopropenyl-13-methyl-(1r,3r,5s,8s,9r,12s,13r,14r)-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione(picrotoxin)
bdbm50017684
(1ar,2ar,3s,6r,6as,8as,8br,9r)-2a-hydroxy-8b-methyl-9-(prop-1-en-2-yl)hexahydro-3,6-methano-1,5,7-trioxacyclopenta[ij]c yclopropa[a]azulene-4,8(3h)-dione
ri5 ,
(5s,8s,12s,1r,3r,9r,13r,14r)-1-hydroxy-13-methyl-14-(1-methylvinyl)-4,7,10-tri oxapentacyclo[6.4.1.1<9,12>.0<3,5>.0<5,13>]tetradecane-6,11-dione
CCG-39761
9k011nuf0r ,
3,6-methano-8h-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3h)-dione, hexahydro-2a-hydroxy-8b-methyl-9-(1-methylethenyl)-, (1ar,2ar,3s,6r,6as,8as,8br,9r)-
unii-9k011nuf0r
picrotoxinin [mi]
SCHEMBL559915
(1r,3r,5s,8s,9r,12s,13r,14r)-1-hydroxy-13-methyl-14-(prop-1-en-2-yl)-4,7,10-trioxapentacyclo[6.4.1.1(9,12).0(3,5).0(5,13)]tetradecane-6,11-dione
AKOS024282617
PIMZUZSSNYHVCU-YKWPQBAZSA-N
picrotoxin (part b)
DTXSID3074311
yclopropa[a]azulene-4,8(3h)-dione
(1ar,2ar,3s,6r,6as,8as,8br,9r)-2a-hydroxy-8b-methyl-9-(prop-1-en-2-yl)hexahydro-3,6-methano-1,5,7-trioxacyclopenta[ij]c
(1ar,2ar,3s,6r,6as,8as,8br,9r)-2a-hydroxy-8b-methyl-9-(prop-1-en-2-yl)hexahydro-3,6-methano-1,5,7-trioxacyclopenta[ij]cyclopropa[a]azulene-4,8(3h)-dione
HY-B1494
Q27088387
3,6-methano-8h-1,5,7-trioxacyclopenta[ij]cycloprop[a]azulene-4,8(3h)-dione, hexahydro-2a-hydroxy-8b-methyl-9-(1-methylethenyl)-, (1ar,2ar,3s,6r,6as,8as,8br,9r)-
CS-0013192
MS-24176
(1r,3r,5s,8s,9r,12s,13r,14r)-1-hydroxy-13-methyl-14-prop-1-en-2-yl-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The method was applied to a pharmacokinetic study following intraperitoneal (i."( Simultaneous determination of the two components of picrotoxin in serum by reversed-phase high-performance liquid chromatography with application to a pharmacokinetic study in rats.
Aguilar-Veiga, E; Galan-Valiente, J; Mendez-Alvarez, E; Sierra-Marcuño, G; Sierra-Paredes, G; Soto-Otero, R, 1989
)
0.28

Bioavailability

ExcerptReferenceRelevance
", ip) indicate that the liver is the primary site of biotransformation of the compound, suggesting that both 22a and its metabolite(s) are active, compensating probably low bioavailability of the parent molecule."( Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E, 2016
)
0.43

Dosage Studied

PB shifted the dose-response curve for GABA in the presence of bicuculline methochloride to the left without altering the slope or the dose ratio. It restored the slope and the maximum response towards that of the control GABA-induced response.

ExcerptRelevanceReference
" The dose-response relationships for GABA antagonism of [3H]alpha-dihydropicrotoxinin binding and for picrotoxinin antagonism of the GABA enhancement of [3H]flunitrazepam binding in cultured cortical neurons were also investigated."( The picrotoxinin binding site and its relationship to the GABA receptor complex.
Dichter, MA; Snodgrass, SR; White, WF, 1985
)
0.27
" PB shifted the dose-response curve for GABA in the presence of bicuculline methochloride to the left without altering the slope or the dose ratio, and not only displaced the dose-response curve for GABA in the presence of picrotoxinin but also restored the slope and the maximum response towards that of the control GABA-induced response."( Potentiation of GABAA-receptor-mediated responses by barbiturates in the guinea-pig ileum.
Kerr, DI; Ong, J, 1984
)
0.27
" In the case of the wild type receptor, fipronil blocked GABA-induced currents inducing both a shift to the right in the GABA dose-response curve and depressing the maximum amplitude of responses to GABA."( Actions of the insecticide fipronil, on dieldrin-sensitive and- resistant GABA receptors of Drosophila melanogaster.
Baylis, HA; Buckingham, SD; Hosie, AM; Sattelle, DB, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
GABA antagonistA compound that inhibits the action of gamma-aminobutyric acid.
serotonergic antagonistDrugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
organic heteropentacyclic compound
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
gamma-lactoneA lactone having a five-membered lactone ring.
picrotoxane sesquiterpenoidA group of sesquiterpenoids whose structure is based on a hexahydroindane skeleton, as exemplified by picrotin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency0.63100.044717.8581100.0000AID485294
TDP1 proteinHomo sapiens (human)Potency12.43470.000811.382244.6684AID686978; AID686979
IDH1Homo sapiens (human)Potency5.80480.005210.865235.4813AID686970
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
gemininHomo sapiens (human)Potency14.58100.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)IC50 (µMol)2.40000.00150.80445.0740AID357441
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (48)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID357660Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 3 uM at +50 mV voltage by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
AID357463Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in glycine-evoked recovery time constant at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357441Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID71561Displacement of [35S]TBPS from GABA-A receptor of rat brain membranes1986Journal of medicinal chemistry, Jan, Volume: 29, Issue:1
Stereoselective syntheses of the trans-decahydroquinoline-5-carboxylic acid epimers. Diastereomeric zwitterionic probes of gamma-aminobutyric acid related biological properties in vitro and in vivo.
AID340274Inhibition of chloride channel2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
AID1336371Displacement of [35S]TBPS from rat cerebral cortex GABA-gated chloride channel measured after 60 mins by scintillation counting method2017Bioorganic & medicinal chemistry, 01-15, Volume: 25, Issue:2
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
AID752202Binding affinity to GABA-gated chloride channel (unknown origin) by radioligand displacement assay2013Bioorganic & medicinal chemistry, May-15, Volume: 21, Issue:10
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
AID1102000Antifeedant activity against adult of Leptinotarsa decemlineata in Capsicum annuum by choice test2002Journal of agricultural and food chemistry, Nov-20, Volume: 50, Issue:24
Antifeedant effects of marine halogenated monoterpenes.
AID346469Displacement of radiolabeled picrotoxinin from verapamil site of L-type GABA-gated chloride channel site 22008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
AID357442Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 30 uM glycine-elicited current at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1101999Antifeedant activity against adult of Myzus persicae (green peach aphid) in Hordeum vulgare by choice test2002Journal of agricultural and food chemistry, Nov-20, Volume: 50, Issue:24
Antifeedant effects of marine halogenated monoterpenes.
AID357450Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of deactivation time constant by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357456Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in channel mean open time by outside patch clamp technique relative to control2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357459Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as change in rising time constant of glycine response at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357454Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in channel mean open time at 10 uM by outside patch clamp technique relative to control2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357460Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as change in relative area of rising time constant of glycine response at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID1101998Antifeedant activity against adult of Rhopalosiphum padi in Hordeum vulgare by choice test2002Journal of agricultural and food chemistry, Nov-20, Volume: 50, Issue:24
Antifeedant effects of marine halogenated monoterpenes.
AID751838Binding affinity to GABA-gated chloride channel (unknown origin) by radioligand displacement assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID357457Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as decrease in activation phase of glycine response at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID566352Inhibition of rat chloride channel2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1285672Displacement of [125I]TBPS from rat cerebral cortex GABA-gated chloride channel2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
AID357466Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as shortened deactivation phase of glycine-evoked response at 10 uM administered before glycine challenge by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357443Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357447Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 3 uM at +50 mV voltage by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357440Inhibition of rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as inhibition of 300 uM glycine-elicited current at 3 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357451Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as shortened single receptor burst opening in response to glycine-pulse at 10 uM by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID357464Effect on rat alpha2 homomeric glycine receptor expressed in CHO cells assessed as glycine-evoked response at 10 uM administered before glycine challenge by outside patch clamp technique2007The Journal of biological chemistry, Jun-01, Volume: 282, Issue:22
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (167)

TimeframeStudies, This Drug (%)All Drugs %
pre-199055 (32.93)18.7374
1990's46 (27.54)18.2507
2000's29 (17.37)29.6817
2010's33 (19.76)24.3611
2020's4 (2.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.47 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews4 (2.53%)6.00%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other154 (97.47%)84.16%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]